• 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 兴业银行获第十二届人民企业社会责任奖年度企业奖 2019-08-02
  • 宝马中国创新日暨上海研发中心揭幕 专注于高新技术 2019-08-01
  • 解放军报评论员:担当起党和人民赋予的新时代使命任务 2019-08-01
  • 别人家的中年男子 听音识木一把琴能卖30万 2019-07-18
  • 《贪婪之秋》延期至2019年 E3新宣传片公开 2019-06-25
  • 《关于发展租赁型职工集体宿舍的意见(试行)》正式发布实施 2019-06-24
  • 网约车陷阱多 谨防四类风险 2019-06-19
  • 太原设禁鸣路段 设备在测试中 2019-06-19
  • 歌浴森专辑写真曝光 俏皮可爱萌态十足 2019-06-09
  • 破11个赛季不胜魔咒 山东客场击败广厦 2019-06-09
  • 喝了6瓶劲酒和1斤白酒 男子手持钢锯在重庆西站撒泼遭控制 2019-06-01
  • 来宝网Logo

    热门词:生物显微镜 水质分析仪 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置时时彩网络平台>技术资料首页>行业动态>公司动态>Gentiva Health将以约10亿美元收购Odyssey HealthCare

    时时彩最准的杀号计划: Gentiva Health将以约10亿美元收购Odyssey HealthCare

    Gentiva Health2010年6月3日 0:49 点击:2068

    时时彩网络平台 www.qlgr.net

    美国Gentiva Health Services Inc


    Gentiva Health将以约10亿美元收购Odyssey HealthCare
    Gentiva健康服务公司週一同意以约10亿美元收购奥德赛(Odyssey)医疗保健公司,交易成行後Gentiva将成为全美最大的家庭护理和临终关怀服务提供商。


    Gentiva同意以每股27美元的价格收购奥德赛,较后者上週五的收盘价溢出40%。


    奥德赛股价(NASDAQ:ODSY)上涨7.32美元或37.95%,至26.61美元;Gentiva股价(NASDAQ:GTIV)上涨3.76美元或14.58%,报29.55美元。


    Gentiva是家庭护理领域的领先公司,一直以来都对加强其临终关怀业务有兴趣;临终关怀服务的专业提供商奥德赛对Gentiva是很有吸引力的目标公司。


    Jefferies的分析师Handerson表示,长期来看,临终关怀服务将成为家庭护理的一个重要分支。对家庭护理服务满意的病人可能也会选择同一个公司来为他们提供临终关怀服务。


    由于两家公司的临终关怀服务的重叠部分并不多,业内分析认为这笔交易不会遭遇监管方面太多的阻力,顺利的话可以在第三季度完成。若不计合并相关的成本将在下一年内提升盈利。Handerson估计,这笔交易至少将为2011财年Gentiva的每股盈利增加20美分。


    两家公司合并后年收入预计将超过18亿美元,在全美30个州每日平均将有1.4万名病人享用服务。


     

    May 24, 2010

    Gentiva Health Services to Acquire Odyssey HealthCare, Creating A Leading US Hospice Care Provider

    - All-cash Transaction for $27 per Odyssey Share - - Conference call scheduled for today, May 24, at 10:00 a.m. ET -

     

    ATLANTA and DALLAS, May 24, 2010 /PRNewswire via COMTEX News Network/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV) ("Gentiva" or "the Company") and Odyssey HealthCare, Inc. (Nasdaq: ODSY) ("Odyssey") announced today that they have entered into a definitive merger agreement whereby Gentiva will acquire Odyssey in an all cash transaction for a price of $27 per share of Odyssey common stock, for an aggregate purchase price of approximately $1.0 billion.

    Founded in 1996 and based in Dallas, Texas, Odyssey is one of the leading providers of hospice care in the US in terms of both average daily patient census and number of locations. Gentiva, which is among the leading home healthcare providers in the US, anticipates that the combination of Odyssey's and Gentiva's existing hospice operations will create a leading hospice care provider in the US, with a combined average daily patient census of approximately 14,000 and operations in 30 states. Additionally, we anticipate the combination of the two companies will create the largest US healthcare provider focused on home health and hospice services.

    Based on results from continuing operations for the respective companies' 2009 fiscal years, we anticipate that the combination of Gentiva and Odyssey will create a company with more than $1.8 billion in annual revenue, comprised of approximately 60% in home healthcare revenue and approximately 40% in hospice revenue. Gentiva expects the transaction to be accretive to adjusted earnings per share, exclusive of one-time costs, within the first 12 months following closing.

    "We are delighted to welcome the Odyssey employees to the Gentiva family," said Gentiva CEO and President Tony Strange. "The combination of the two companies clearly positions us as a leader in both home health and hospice care in the United States. The two companies share similar geography between Gentiva's home health operations and Odyssey's hospice operations, with very little overlap between the two companies' hospice programs. We believe that Odyssey is the nation's premiere hospice provider and we are excited to partner with an organization that shares our commitment to quality patient care."

    "This agreement represents an exciting opportunity to provide Odyssey's stockholders with significant, immediate and certain value, while also accelerating our strategy," said Robert A. Lefton, President and Chief Executive Officer of Odyssey HealthCare. "With Gentiva, we are bringing together two complementary businesses that are positioned for continued leadership in the hospice industry. We believe Gentiva shares our commitment for compassionate, personalized care, and we look forward to better serving our patients and their families with the enhanced resources and depth of the combined company."

    The transaction was unanimously approved by the Board of Directors of Gentiva. Odyssey's Board of Directors has also unanimously approved the agreement and recommended that Odyssey's shareholders approve the merger.

    The transaction is expected to close in the third quarter of 2010 and is subject to standard closing conditions, including regulatory approvals and clearance under the Hart-Scott-Rodino Act as well as approval by Odyssey's stockholders. Gentiva expects to raise approximately $1.1 billion in new debt financing to fund the purchase price and to refinance existing debt. The Company has secured a financing commitment for the transaction from a syndicate of leading financial institutions, including BofA Merrill Lynch, Barclays Bank PLC, General Electric Capital Corporation, and SunTrust Bank and SunTrust Robinson Humphrey, Inc.

    Edge Healthcare Partners, LLC, a division of Edge Corporate Finance, LLC is acting as financial advisor to Gentiva. Greenberg Traurig, LLP is acting as legal advisor to Gentiva. BofA Merrill Lynch and Barclays Capital Inc. served as advisors to Gentiva and both firms are serving in lead advisor roles with respect to the financing of the transaction.

    Goldman, Sachs & Co. is acting as financial advisor to the Board of Directors of Odyssey. K&L Gates LLP is acting as legal advisor to Odyssey.

    Cahill Gordon & Reindel LLP is acting as legal advisor to the financing sources.

    Conference Call and Webcast Details

    The Company will comment further on the transaction during a conference call and live webcast to be held Monday, May 24, 2010 at 10:00 a.m. Eastern Time. To participate in the call from the United States, Canada or an international location, dial (973) 935-2408 and reference call # 77766759. The webcast is an audio-only, one-way event. Webcast listeners who wish to ask questions must participate in the conference call. Log onto //investors.gentiva.com/events.cfm to hear the webcast. A replay of the call will be available on May 24, beginning at approximately 1:00 p.m. ET, and will remain available continuously through May 31. To listen to a replay of the call from the United States, Canada or international locations, dial (800) 642-1687 or (706) 645-9291 and enter the following PIN at the prompt: 77766759. Visit //investors.gentiva.com/events.cfm to access the webcast archive. This press release is accessible at //investors.gentiva.com/releases.cfm and a transcript of the conference call is expected to be available on the site within 48 hours after the call.

    About Odyssey HealthCare, Inc.

    Based in Dallas, Texas, Odyssey is one of the largest providers of hospice care in the country in terms of both average daily patient census and number of locations. Odyssey seeks to improve the quality of life of terminally ill patients and their families by providing care directed at managing pain and other discomforting symptoms and by addressing the psychosocial and spiritual needs of patients and their families.

    About Gentiva Health Services, Inc.

    Gentiva Health Services, Inc. is a leading provider of home health and hospice services, delivering innovative, high quality care to patients across the United States. Gentiva is a single source for skilled nursing; physical, occupational, speech and neurorehabilitation services; hospice services; social work; nutrition; disease management education; help with daily living activities; and other therapies and services. For more information, visit Gentiva's web site, //www.gentiva.com, and its investor relations section at //investors.gentiva.com. GTIV-G

    Additional Information and Where to Find It

    Odyssey intends to file with the Securities and Exchange Commission a preliminary proxy statement and a definitive proxy statement and other relevant materials in connection with the transaction. The definitive proxy statement will be sent or given to the stockholders of Odyssey. Before making any voting or investment decision with respect to the transaction, investors and stockholders of Odyssey are urged to read the proxy statement and the other relevant materials when they become available because they will contain important information about the transaction. The proxy statement and other relevant materials (when they become available), and any other documents filed by Odyssey with the SEC, may be obtained free of charge at the SEC's website at www.sec.gov, or from Odyssey by directing a request to Odyssey's Investor Relations Department at toll free phone number 888-922-9711, email address [email protected] or through the Odyssey Web site www.odsyhealth.com under "Investor Relations -- InfoRequest".

    Participants in the Solicitation

    Odyssey and its directors and executive officers may be deemed to be participants in the solicitation of proxies from Odyssey stockholders in connection with the transaction. Information about Odyssey's directors and executive officers is set forth in Odyssey's proxy statement on Schedule 14A filed with the SEC on April 5, 2010 and Odyssey's Annual Report on Form 10-K filed on March 10, 2010. Additional information regarding the interests of participants in the solicitation of proxies in connection with the merger will be included in the proxy statement that Odyssey intends to file with the SEC.

    Forward-Looking Statement

    This press release contains forward-looking statements that involve risks, uncertainties and assumptions. If such risks or uncertainties materialize or such assumptions prove incorrect, the results of Gentiva and its consolidated subsidiaries could differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including the expected benefits and costs of the transaction; management plans relating to the transaction; the expected timing of the completion of the transaction; the ability to complete the transaction considering the various closing conditions, including those conditions related to regulatory approvals; any statements of the plans, strategies and objectives of management for future operations, including the execution of integration plans; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing. Risks, uncertainties and assumptions include the possibility that expected benefits may not materialize as expected; that the transaction may not be timely completed, if at all; that, prior to the completion of the transaction, the target company's business may not perform as expected due to transaction-related uncertainty or other factors; that the parties are unable to successfully implement integration strategies; and other risks that are described in Gentiva's SEC reports, including but not limited to the risks described in Gentiva's Annual Report on Form 10-K for its fiscal year ended January 3, 2010. Gentiva assumes no obligation and does not intend to update these forward-looking statements.

        For Further Information
    
        For Gentiva:
    
        Financial and Investor Contact:
                Eric Slusser
                770-951-6101
                [email protected]
        or     Brandon Ballew
                770-221-6700
                [email protected]
    
        Media Contact:
                Scott Cianciulli
                Brainerd Communicators
                212-986-6667
                [email protected]
    
        For Odyssey HealthCare:
    
        Investors:
                R. Dirk Allison
                Senior Vice President and Chief Financial Officer, Odyssey
                 HealthCare, Inc.
                214-922-9711
    
        Media:
                Andy Brimmer / Tim Lynch
                Joele Frank, Wilkinson Brimmer Katcher
                212-355-4449
    
    
    
    

    SOURCE Gentiva Health Services, Inc.


     

    (来源: Gentiva Health )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, 时时彩网络平台,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。


  • 李克强:扩大跨省异地就医直接结算范围 2019-08-11
  • 次仁卓玛一家的端午节 2019-08-11
  • 市人大常委会召开党组会议传达学习全国两会精神张轩主持并讲话 2019-08-09
  • 世界杯期间在家撸串的正确姿势-热门标签-华商网数码 2019-08-06
  • 兴业银行获第十二届人民企业社会责任奖年度企业奖 2019-08-02
  • 宝马中国创新日暨上海研发中心揭幕 专注于高新技术 2019-08-01
  • 解放军报评论员:担当起党和人民赋予的新时代使命任务 2019-08-01
  • 别人家的中年男子 听音识木一把琴能卖30万 2019-07-18
  • 《贪婪之秋》延期至2019年 E3新宣传片公开 2019-06-25
  • 《关于发展租赁型职工集体宿舍的意见(试行)》正式发布实施 2019-06-24
  • 网约车陷阱多 谨防四类风险 2019-06-19
  • 太原设禁鸣路段 设备在测试中 2019-06-19
  • 歌浴森专辑写真曝光 俏皮可爱萌态十足 2019-06-09
  • 破11个赛季不胜魔咒 山东客场击败广厦 2019-06-09
  • 喝了6瓶劲酒和1斤白酒 男子手持钢锯在重庆西站撒泼遭控制 2019-06-01
  • 澳门银河电子游戏ga 极速11选5玩法 新疆时时彩3d中奖 河南快3开奖结果查询结果是 福建36选7开奖玩法 四川金7乐昨日开奖结果 005期红心水论坛 澳洲幸运8开奖数结果 3d专家杀号彩宝贝 儿童象棋残局入门 2019排球东京奥运资格赛 11选5开奖结果走势图 双色球2元一等奖多少钱 哪些平台可以买彩票 山西十一选五前二直选